Barely Significant
← all excerpts

Increased plasma GPNMB levels in patients with parkinson's disease and cognitive impairment.

Sci Rep · 2025 · PMC12214917 · PMID 40594632

Europe PMCDOI
1
hedged sentence
0.3200
closest p · 6.4× alpha
0.3200
boldest claim

The sentences

a nonsignificant trendp = 0.32not close (p > 0.1)
Interestingly, when comparing GPNMB levels across different disease stages within the same cognitive status groups, we observed a nonsignificant trend toward higher levels in patients with advanced-stage PD than in patients with early-stage PD (PD-NC: 24.21 ± 0.82 vs. 25.77 ± 1.48, p = 0.32; PD-CI: 30.22 ± 0.93 vs. 31.16 ± 1.42, p = 0.56).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.